|
HY-130841-100mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130841-25mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130841-5mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130841-50mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130841-1mL
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P74382-10ug
|
MedChemexpress LLC
|
Beta-Catenin, Human (sf9, His-GST)
|
|
|
|
|
HY-P74382-5ug
|
MedChemexpress LLC
|
Beta-Catenin, Human (sf9, His-GST)
|
|
|
|
|
HY-P74382-50ug
|
MedChemexpress LLC
|
Beta-Catenin, Human (sf9, His-GST)
|
|
|
|
|
HY-P78753-10ug
|
MedChemexpress LLC
|
CD3 gamma, Human (HEK293, Fc)
|
|
|
|
|
HY-P78753-5ug
|
MedChemexpress LLC
|
CD3 gamma, Human (HEK293, Fc)
|
|
|
|
|
HY-P78753-50ug
|
MedChemexpress LLC
|
CD3 gamma, Human (HEK293, Fc)
|
|
|
|
|
HY-103255-10mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
|
HY-103255-25mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
|
HY-103255-5mg
|
MedChemexpress LLC
|
CFM-4 [CAS 331458-02-7]
|
|
Cancer-programmed cell death
|
|
|
HY-117930-1mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-10mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-100mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-25mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-5mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-50mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-1mL
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P99933-1mg
|
MedChemexpress LLC
|
Eftilagimod alfa [CAS 1800476-36-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P73090-10ug
|
MedChemexpress LLC
|
GSK-3 Beta, Mouse (sf9, His)
|
|
|
|
|
HY-P73090-20ug
|
MedChemexpress LLC
|
GSK-3 Beta, Mouse (sf9, His)
|
|
|
|
|
HY-P73090-5ug
|
MedChemexpress LLC
|
GSK-3 Beta, Mouse (sf9, His)
|
|
|
|
